FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
Go back to FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.24 -0.71 (5.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.95 | 52 Week High | $2.18 | |||
| Open | $11.41 | 52 Week Low | $0.30 | |||
| Day High | $11.45 | P/E | N/A | |||
| Day Low | $11.22 | EPS | $-3.32 | |||
| Volume | 242,338 | |||||
